Program for Breakthrough Biomedical Research to Celebrate 15 Years

News   May 21, 2013

 
Program for Breakthrough Biomedical Research to Celebrate 15 Years
 
 
 

RELATED ARTICLES

Two Studies Provide Significant Hope in the Fight Against Antibiotic Resistance

News

Two recent studies led by the University of Bristol provide significant new hope in the fight against antibiotic resistance.

READ MORE

Gilead Company Wins FDA Approval for CAR T Cancer Therapy for Treatment of Adult Lymphoma

News

Kite’s Yescarta™ (axicabtagene ciloleucel) becomes first CAR T therapy approved by the FDA for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy.

READ MORE


 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE